Application 206099
- Type
- NDA
- Sponsor
- CURRAX
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ONZETRA XSAIL | SUMATRIPTAN SUCCINATE | POWDER;NASAL | EQ 11MG BASE | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42847-311 | Onzetra Xsail | sumatriptan succinate | Currax Pharmaceuticals LLC | NDA | Current |
| 42847-311 | Onzetra Xsail | sumatriptan succinate | Currax Pharmaceuticals LLC | NDA | Current |
| 42847-311 | Onzetra Xsail | sumatriptan succinate | Currax Pharmaceuticals LLC | NDA | Current |
| 64597-311 | ONZETRA | sumatriptan succinate | Avanir Pharmaceuticals, Inc. | NDA | Current |
| 64597-311 | ONZETRA | sumatriptan succinate | Avanir Pharmaceuticals, Inc. | NDA | Current |